[Cytomegalovirus infection].
Numazaki
K
K
Department of Pediatrics, Sapporo Medical University School of Medicine.
D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000472:pathogenicity; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000635:transmission; D018562:Disease Transmission, Infectious; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011379:Prognosis
D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir